Introgen Anticipates Completion Of Advexin Rolling BLA Submission In 2007

Biologic may have synergistic effects with ImClone’s Erbitux and Genentech’s Avastin, firm tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet